Form 4: RxSight Executive Ilya Goldshleger Executes Stock Option and Sells Shares Under 10b5-1 Plan

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On November 7, 2024, Ilya Goldshleger, Co-President and COO of RxSight, Inc., executed a stock option to acquire 3,100 shares at a price of $15.08 per share.
• Goldshleger also sold 2,900 shares of common stock at a weighted average price of $54.9616, within a price range of $54.41 to $55.26.
• An additional 200 shares were sold at $55.53 per share.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on June 3, 2024.
• Following these transactions, Goldshleger directly owns 42,246 shares and indirectly owns 1,372 shares through a spouse.
• He also holds 59,387 derivative securities (stock options).

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity under a pre-arranged plan.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The use of a 10b5-1 trading plan suggests that the sales were pre-planned and not based on any material non-public information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider information.

Key Dates